Tomasz Kula

Tomasz Kula has a long and impressive work history. Tomasz began their career in 2009 as an Undergraduate Research Fellow at Harvard University. In 2012, they became a Graduate Student at Harvard Medical School, where they were a NSF Graduate Research Fellow and a Biogen Innovation Fellow. Tomasz'stwo main PhD projects were Kula et al. Cell 2019, which developed the TScan system, and Xu* & Kula* et al. Science 2015, which developed the VirScan system. In 2018, they became Co-Founder and Scientific Advisory Board Member of TScan Therapeutics, and in 2020 they became Co-Founder and Scientific Advisory Board Member of ImmuneID. Additionally, in 2020 they became a Junior Fellow at Harvard Society of Fellows, where they are developing high-throughput tools to study the brain.

Tomasz Kula graduated from Harvard University with a Bachelor of Arts in Molecular and Cellular Biology in 2012. Tomasz then continued their studies at Harvard University, receiving a Doctor of Philosophy in Biological and Biomedical Sciences in 2019.